Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity in Pseudomonas aeruginosa
- PMID: 18070070
- DOI: 10.1111/j.1574-6968.2007.00997.x
Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity in Pseudomonas aeruginosa
Abstract
Pseudomonas aeruginosa strains exhibiting a heterogeneous mode of growth against carbapenems have been described recently. This study investigated the underlying molecular mechanisms in four genetically unrelated P. aeruginosa clinical isolates that were previously characterized by population analyses as heterogeneously resistant against carbapenems. Mutant subpopulations of all four isolates had at least fourfold higher minimum inhibitory concentrations than those of native cells for imipenem and meropenem. The heterogeneous subpopulations, when compared with the respective native ones, had significantly increased transcription levels of the mexB and mexY genes (P<0.05), whereas transcription levels of the mexE gene remained unchanged. They also exhibited significantly decreased expression of the oprD gene (P<0.05) and decreased intensity of the protein band of the porin OprD. Upregulation of efflux systems, in part, and the decrease of OprD contribute to the heterogeneous growth against carbapenems in our P. aeruginosa clinical isolates.
Similar articles
-
Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.APMIS. 2005 Mar;113(3):187-96. doi: 10.1111/j.1600-0463.2005.apm1130306.x. APMIS. 2005. PMID: 15799762
-
Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.Pathol Biol (Paris). 2009 Nov-Dec;57(7-8):530-5. doi: 10.1016/j.patbio.2008.09.001. Epub 2008 Oct 31. Pathol Biol (Paris). 2009. PMID: 18977099
-
[The roles of active efflux system overexpression and outer membrane protein OprD deficiency or loss in carbapenem resistance of Pseudomonas aeruginosa].Zhonghua Yi Xue Za Zhi. 2006 Feb 21;86(7):457-62. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16677571 Chinese.
-
[Pseudomonas aeruginosa--a significant hospital pathogen and resistance to carbapenem].Acta Med Croatica. 2004;58(4):313-21. Acta Med Croatica. 2004. PMID: 15700688 Review. Croatian.
-
Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence.Int J Antimicrob Agents. 2012 Jan;39(1):11-5. doi: 10.1016/j.ijantimicag.2011.08.018. Epub 2011 Nov 1. Int J Antimicrob Agents. 2012. PMID: 22047702 Review.
Cited by
-
Pseudomonas aeruginosa heteroresistance to levofloxacin caused by upregulated expression of essential genes for DNA replication and repair.Front Microbiol. 2022 Dec 23;13:1105921. doi: 10.3389/fmicb.2022.1105921. eCollection 2022. Front Microbiol. 2022. PMID: 36620018 Free PMC article.
-
Phenotypic and Molecular Characterization of Carbapenem-Heteroresistant Bacteroides fragilis Strains.Antibiotics (Basel). 2022 Apr 27;11(5):590. doi: 10.3390/antibiotics11050590. Antibiotics (Basel). 2022. PMID: 35625234 Free PMC article.
-
Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa.Infect Drug Resist. 2020 May 14;13:1419-1428. doi: 10.2147/IDR.S249475. eCollection 2020. Infect Drug Resist. 2020. PMID: 32523360 Free PMC article.
-
Antimicrobial heteroresistance: an emerging field in need of clarity.Clin Microbiol Rev. 2015 Jan;28(1):191-207. doi: 10.1128/CMR.00058-14. Clin Microbiol Rev. 2015. PMID: 25567227 Free PMC article. Review.
-
Antibiotic Heteroresistance in Klebsiella pneumoniae.Int J Mol Sci. 2021 Dec 31;23(1):449. doi: 10.3390/ijms23010449. Int J Mol Sci. 2021. PMID: 35008891 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical